Previous PostBellicum Pharmaceuticals: Bellicum Reports Safety Results and Promising Activity of Its Controlled CAR-T Candidate BPX-601 in Patients with Advanced Pancreatic Cancer at ESMO-IO
Next PostNuMat Technologies Partnership to Protect and Sustain Modern Warfighter with Dual-Use Technology
